Form 4: Molina Healthcare Director Orlando Acquires Shares

Molina Healthcare Director Steven J. Orlando acquired 285 shares of common stock as part of his director compensation plan.

Summary

• Director Steven J. Orlando acquired 285 shares of Molina Healthcare, Inc. common stock.
• The acquisition occurred on October 1, 2025, at a price of $192.79 per share.
• This grant is part of the Issuer's 2025 Equity Incentive Plan, specifically for his services as a Director.
• The annual equity award for directors is $220,000, with $55,000 granted quarterly.
• Following this transaction, Orlando beneficially owns 17,008 shares indirectly through the Orlando Family Trust and 1,500 shares indirectly through his 401(k).

Sentiment

Score: 7

Explanation: The filing reports a routine, pre-scheduled equity grant to a director, which is a positive for aligning management interests with shareholders but does not indicate any new significant operational or financial developments.

Positives

• Director Steven J. Orlando received an equity grant of 285 shares, aligning his interests with shareholders.
• The grant is part of a structured 2025 Equity Incentive Plan, indicating a clear compensation strategy for directors.

Future Outlook

The filing indicates that quarterly grants are part of an ongoing 2025 Equity Incentive Plan, suggesting continued equity-based compensation for directors.

Management Comments

• Grant of stock under the Issuer's 2025 Equity Incentive Plan in connection with the Reporting Person's services as a Director.

Industry Context

Equity grants to directors are a standard practice across industries, particularly in healthcare, to align leadership interests with long-term company performance and shareholder value.

Comparison to Industry Standards

• Equity compensation for directors, such as stock grants, is a common practice in publicly traded companies, including those in the healthcare sector like UnitedHealth Group (UNH) or Anthem (ANTM), to incentivize long-term commitment and align interests with shareholders.
• The specific value of the annual equity award ($220,000) and quarterly grants ($55,000) would typically be benchmarked against peer companies of similar market capitalization and industry within the healthcare services sector to ensure competitive director compensation.
• The use of a 2025 Equity Incentive Plan is standard for establishing a framework for such awards, similar to plans seen at other large healthcare providers.

Corporate Governance

Related Party Transactions

• The grant of 285 shares to Director Steven J. Orlando as part of his compensation under the 2025 Equity Incentive Plan.

Stakeholder Impact

• Shareholders: Director's increased ownership aligns interests with shareholders, potentially fostering long-term value creation.
• Management/Directors: Provides equity-based compensation, incentivizing performance and retention.

Next Steps

• Future quarterly equity grants to directors are expected under the 2025 Equity Incentive Plan.

Key Dates

Recommendation

This Form 4 reports a routine, pre-scheduled equity grant to a director as part of their compensation. While it indicates alignment of interests, it does not provide new material information that would warrant a change in investment recommendation. It's a standard operational event.

Keywords

Molina Healthcare, MOH, Steven J. Orlando, Director Compensation, Stock Grant, Equity Incentive Plan, Insider Trading, Form 4, Beneficial Ownership